Tag: IL-17A inhibitor
Novartis’ Scapho shows pioneering 4-year data in preventing Ankylosing Spondylitis progression
For the first time for any biologic, data show almost 80 percent of ankylosing spondylitis (AS) patients on Scapho have no radiographic progression of the spine at 4 years.......